Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
other: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
April, 1977
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1978
Report date:
1978

Materials and methods

Principles of method if other than guideline:
5/mouse/sex were dosed by a single intraperitoneal dose of 2000 mg/kg; observation were carried out for 14 days after dosing.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Reference substance name:
Similar Substance 01
IUPAC Name:
Similar Substance 01
Test material form:
solid: particulate/powder

Test animals

Species:
mouse
Strain:
CD-1
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River (U.K.) Ltd.
- Weight at study initiation: 17 - 24 g
- Fasting period before study: for 18 - 20 hours before treatment
- Housing: in groups of 5 by sex
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 3 days.

ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 50 ± 10 %
- Photoperiod: natural light conditions

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
water
Details on exposure:
A single intraperitoneal dose (2000 mg/kg) of test material, based on the individual fasted body weight of the animais at the time of treatment.
Doses:
2000 mg/kg
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations for overt toxicity and mortality at 15 min, 1, 2 and 4 hours after treatment and subsequently once daily for 14 days; body weights of survivors were recorded 14 days after treatment.
- Necropsy of survivors performed: no
- Other examinations performed: no

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
EC50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Sex:
male/female
Dose descriptor:
EC0
Effect level:
ca. 2 000 mg/kg bw
Based on:
test mat.
Mortality:
None.
Clinical signs:
No signs of overt toxicity.
Body weight:
Normal body weight gain.

Applicant's summary and conclusion

Conclusions:
LD50 > 2000 mg/kg.
Executive summary:

Method

Acute intraperitoneal toxicity was assessed by dosing 5 mice/sex/dose by intraperitoneal route at dose of 2000 mg/kg. Observations were carried out for 14 days after dosing.

Results

No deaths occurred and no signs of overt toxicity were noted, thus LD50 > 2000 mg/kg.